This inventor holds 12 USPTO granted patents. Top assignees: University of Michigan, Johns Hopkins University. Active years: 1981-2005.
Location History:
- Ann Arbor, MI (US) (1981 - 2000)
- Menlo Park, CA (US) (2001 - 2005)
Company Filing History:
Years Active: 1981-2005
Title: The Innovations of Norman S. Radin
Introduction
Norman S. Radin is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of biochemistry, particularly in the development of novel therapeutic compounds. With a total of 12 patents to his name, Radin's work has had a substantial impact on medical science.
Latest Patents
One of Radin's latest patents involves amino ceramide-like compounds and their therapeutic methods of use. These novel compounds inhibit glucosyl ceramide (GlcCer) formation by targeting the enzyme GlcCer synthase. This inhibition leads to a reduction in glycosphingolipid levels, which is crucial for treating various conditions and diseases associated with altered glycosphingolipid levels. The compounds developed by Radin exhibit improved GlcCer synthase inhibition activity, making them highly useful in therapeutic applications.
Career Highlights
Throughout his career, Norman S. Radin has worked with esteemed institutions such as the University of Michigan and Johns Hopkins University. His research has focused on innovative solutions to complex biochemical problems, contributing to advancements in therapeutic methods.
Collaborations
Radin has collaborated with notable colleagues, including James A. Shayman and Saul W. Brusilow. These partnerships have fostered a collaborative environment that has enhanced the quality and impact of his research.
Conclusion
Norman S. Radin's contributions to the field of biochemistry through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to influence therapeutic methods and improve health outcomes.